Artificial stone silicosis.


Journal

Current opinion in allergy and clinical immunology
ISSN: 1473-6322
Titre abrégé: Curr Opin Allergy Clin Immunol
Pays: United States
ID NLM: 100936359

Informations de publication

Date de publication:
01 04 2021
Historique:
pubmed: 18 12 2020
medline: 1 12 2021
entrez: 17 12 2020
Statut: ppublish

Résumé

This review details recent findings related to the health effects of occupational exposure to artificial stone dust and the rapid increase in cases of artificial stone associated silicosis around the world. High crystalline silica content artificial stone is now commonly used for the production of kitchen benchtops. Reports of artificial stone silicosis from many countries have noted that workers were typically employed at small workplaces and were often diagnosed in their 30s or 40s. Poor exposure control measures were common, including the practice of 'dry processing'. Dust generated from artificial stone has been noted to have properties that influence toxicity, including high silica content, generation of nanosized particles and presence of metals and resins. Artificial stone silicosis differs from silicosis associated with other occupational settings including shorter latency and rapid disease progression. High-resolution computed tomography (CT) chest imaging of artificial stone silicosis has often noted the presence of ground glass opacities, which may not be detected in chest x-ray screening. Increased prevalence of autoimmune disease, such as scleroderma, has also been reported in this industry. Further evaluation of the safety of work with artificial stone is required, including the effectiveness of dust control measures. Current reports of artificial stone silicosis indicate the potential for widespread undiagnosed respiratory disease in this industry. Provision of more sensitive health screening methods for all at-risk workers and the development of new treatment options particularly for this form of silicosis is urgently required.

Identifiants

pubmed: 33332924
doi: 10.1097/ACI.0000000000000715
pii: 00130832-202104000-00004
doi:

Substances chimiques

Dust 0
Silicon Dioxide 7631-86-9

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

114-120

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Références

Yurdasal B, Bozkurt N, Bozkurt AI, Yilmaz O. The evaluation of the dust-related occupational respiratory disorders of dental laboratory technicians working in Denizli Province. Ann Thorac Med 2015; 10:249–255.
Akgun M. Denim production and silicosis. Curr Opin Pulm Med 2016; 22:165–169.
Martinez C, Prieto A, Garcia L, et al. Silicosis: a disease with an active present. Arch Bronconeumol 2010; 46:97–100.
Kramer MR, Blanc PD, Fireman E, et al. Artificial stone silicosis [corrected]: disease resurgence among artificial stone workers. Chest 2012; 142:419–424.
Newbigin K, Parsons R, Deller D, et al. Stonemasons with silicosis: preliminary findings and a warning message from Australia. Respirology 2019; 24:1220–1221.
Cohen RA, Go LHT. Artificial stone silicosis: removal from exposure is not enough. Chest 2020; 158:862–863.
Breton Compound Stone - Technology and Plants [Internet]. [cited 2020, Dec 7]. Italy. Available from: https://www.breton.it/en/engineered-stone/bretonstone-slabs .
Wu N, Xue C, Yu S, Ye Q. Artificial stone-associated silicosis in China: a prospective comparison with natural stone-associated silicosis. Respirology 2020; 25:518–524.
Rose C, Heinzerling A, Patel K, et al. Severe silicosis in engineered stone fabrication workers: California, Colorado, Texas, and Washington, 2017–2019. MMWR Morb Mortal Wkly report 2019; 68:813–818.
Caesarstone. Investor presentation Caesarstone. August, 2020.
Hoy RF, Baird T, Hammerschlag G, et al. Artificial stone-associated silicosis: a rapidly emerging occupational lung disease. Occup Environ Med 2018; 75:3–5.
Perez-Alonso A, Cordoba-Dona JA, Millares-Lorenzo JL, et al. Outbreak of silicosis in Spanish quartz conglomerate workers. Int J Occup Environ Health 2014; 20:26–32.
León-Jiménez A, Hidalgo-Molina A, Conde-Sánchez M, et al. Artificial stone silicosis: rapid progression following exposure cessation. Chest 2020; 158:1060–1068.
Guarnieri G, Salasnich M, Lucernoni P, et al. Silicosis in finishing workers in quartz conglomerates processing. Med Lav 2020; 111:99–106.
Leso V, Fontana L, Romano R, et al. Artificial stone associated silicosis: a systematic review. Int J Environ Res Public Health 2019; 16:568.
Carrieri M, Guzzardo C, Farcas D, Cena LG. Characterization of silica exposure during manufacturing of artificial stone countertops. Int J Environ Res Public Health 2020; 17:4489.
Qi C, Lo L-M. In-depth survey report: engineering control of silica dust from stone countertop fabrication and installation. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, EPHB 375-12a, 2016 Sep; 1-27. Cincinnati, OH: USA.
Ophir N, Bar Shai A, Korenstein R, et al. Functional, inflammatory and interstitial impairment due to artificial stone dust ultrafine particles exposure. Occup Environ Med 2019; 76:875–879.
Zhuang Z, Viscusi D. Respiratory protection for workers handling engineered nanoparticles [Internet]; 2011. [updated 2018; cited 2020, Dec 7] Centers for Disease Control and Prevention, Atlanta, Georgia. Available from: https://blogs.cdc.gov/niosh-science-blog/2011/12/07/resp-nano/ .
Tcharkhtchi A, Abbasnezhad N, Zarbini Seydani M, et al. An overview of filtration efficiency through the masks: mechanisms of the aerosols penetration. Bioact Mater 2021; 6:106–122.
Thorley AJ, Ruenraroengsak P, Potter TE, Tetley TD. Critical determinants of uptake and translocation of nanoparticles by the human pulmonary alveolar epithelium. ACS Nano 2014; 8:11778–11789.
Ferri C, Artoni E, Sighinolfi GL, et al. High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: possible pathogenetic role in disease phenotypes. Semin Arthritis Rheum 2018; 48:475–481.
Buchanan D, Miller BG, Soutar CA. Quantitative relations between exposure to respirable quartz and risk of silicosis. Occup Environ Med 2003; 60:159–164.
American Conference of Governmental Industrial Hygienists. Guide to Occupational Exposure Values. American Conference of Governmental Industrial Hygienists; 2014. Cincinnati, OH: USA.
Cooper JH, Johnson DL, Phillips ML. Respirable silica dust suppression during artificial stone countertop cutting. Ann Occup Hyg 2015; 59:122–126.
Di Benedetto F, Giaccherini A, Montegrossi G, et al. Chemical variability of artificial stone powders in relation to their health effects. Sci Rep 2019; 9:6531.
Pavan C, Polimeni M, Tomatis M, et al. Editor's highlight: abrasion of artificial stones as a new cause of an ancient disease. Physicochemical features and cellular responses. Toxicol Sci 2016; 153:4–17.
Ophir N, Shai AB, Alkalay Y, et al. Artificial stone dust-induced functional and inflammatory abnormalities in exposed workers monitored quantitatively by biometrics. ERJ Open Res 2016; 2:
Judson MA. Environmental risk factors for sarcoidosis. Front Immunol 2020; 11:1340.
Lopes-Pacheco M, Bandeira E, Morales MM. Cell-based therapy for silicosis. Stem Cells Int 2016; 2016:5091838.
Suojalehto H, Sastre J, Merimaa E, et al. Occupational asthma from epoxy compounds. J Allergy Clin Immunol Pract 2019; 7:191–198.
Hines SE, Barker EA, Robinson M, et al. Cross-sectional study of respiratory symptoms, spirometry, and immunologic sensitivity in epoxy resin workers. Clin Transl Sci 2015; 8:722–728.
Pascual Del Pobil YFMA, Garcia Sevila R, Garcia Rodenas MDM, et al. Silicosis: a former occupational disease with new occupational exposure scenarios. Rev Clin Esp 2019; 219:26–29.
Frankel A, Yates BL. Complicated silicosis in an Australian worker from cutting engineered stone: an embarrassing first for Australia. Eur Respir J 2015; 46: (Suppl 59): 1144.
Background to silicosis: WorkCover Queensland; 2020. https://www.worksafe.qld.gov.au/silicosis/background-to-silicosis .
Wang CW, Colby TV. Histiocytic lesions and proliferations in the lung. Semin Diagn Pathol 2007; 24:162–182.
Guarnieri G, Bizzotto R, Gottardo O, et al. Multiorgan accelerated silicosis misdiagnosed as sarcoidosis in two workers exposed to quartz conglomerate dust. Occup Environ Med 2019; 76:178–180.
Levin K, McLean C, Hoy R. Artificial stone-associated silicosis: clinical-pathological-radiological correlates of disease. Respirol Case Rep 2019; 7:e00470.
Grubstein A, Shtraichman O, Fireman E, et al. Radiological evaluation of artificial stone silicosis outbreak: emphasizing findings in lung transplant recipients. J Comput Assist Tomogr 2016; 40:923–927.
Jones CM, Pasricha SS, Heinze SB, MacDonald S. Silicosis in artificial stone workers: spectrum of radiological high-resolution CT chest findings. J Med Imaging Radiat Oncol 2020; 64:241–249.
Awab A, Khan MS, Youness HA. Whole lung lavage-technical details, challenges and management of complications. J Thorac Dis 2017; 9:1697–1706.
Stafford M, Cappa A, Weyant M, et al. Treatment of acute silicoproteinosis by whole-lung lavage. Semin Cardiothorac Vasc Anesth 2013; 17:152–159.
Cavalli G, Fallanca F, Dinarello CA, Dagna L. Treating pulmonary silicosis by blocking interleukin 1. Am J Respir Crit Care Med 2015; 191:596–598.
Biswas R, Trout KL, Jessop F, et al. Imipramine blocks acute silicosis in a mouse model. Part Fibre Toxicol 2017; 14:36.
Wollin L, Distler JHW, Redente EF, et al. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases. Eur Respir J 2019; 54:
Guo J, Yang Z, Jia Q, et al. Pirfenidone inhibits epithelial-mesenchymal transition and pulmonary fibrosis in the rat silicosis model. Toxicol Lett 2019; 300:59–66.
Rosengarten D, Fox BD, Fireman E, et al. Survival following lung transplantation for artificial stone silicosis relative to idiopathic pulmonary fibrosis. Am J Ind Med 2017; 60:248–254.
Hoy RF, Chambers DC. Silica-related diseases in the modern world. Allergy 2020; 75:2805–2817.
Shtraichman O, Blanc PD, Ollech JE, et al. Outbreak of autoimmune disease in silicosis linked to artificial stone. Occup Med (Lond) 2015; 65:444–450.
Guha N, Straif K, Benbrahim-Tallaa L. The IARC Monographs on the carcinogenicity of crystalline silica. Med Lav 2011; 102:310–320.
Sato T, Shimosato T, Klinman DM. Silicosis and lung cancer: current perspectives. Lung Cancer (Auckl) 2018; 9:91–101.
Ahn YS, Jeong KS. Epidemiologic characteristics of compensated occupational lung cancers among Korean workers. J Korean Med Sci 2014; 29:1473–1481.
Qi C, Echt A. In-depth survey report: engineering control of silica dust from stone countertop fabrication and installation. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, EPHB 375-11a, 2016 Mar; :1-22. Cincinnati, OH: USA.

Auteurs

Ryan F Hoy (RF)

School of Public Health & Preventive Medicine Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH